Angiotensin-converting enzyme gene polymorphism in chronic allograft nephropathy. 2006

P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
Molecular Biology, Medical School of São José do Rio Preto, São José do Rio Preto, Brazil.

Angiotensin causes an increased activity of hypertrophic and fibrotic processes, which similarly develop in the walls of small vessels of a renal graft during chronic rejection. In this context, the angiotensin-converting enzyme (ACE) gene, associated with increased angiotensin production, has been the subject of studies on renal diseases. The present study evaluated the influence of the ACE gene deletion polymorphism in chronic allograft nephropathy. We evaluated 240 renal transplant recipients including, 119 with normal renal function and 121 with chronic allograft nephropathy. The polymorphism was determined by polymerase chain reaction and genotyping performed after electrophoresis in 1.5% agarose gels stained with ethidium bromide. The frequency of the polymorphic allele was similar in both groups of patients. Furthermore, no significant effect of genotype was observed in chronic allograft nephropathy. Therefore, in this study, we observed no influence of the ACE gene polymorphism in chronic allograft nephropathy.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies

Related Publications

P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
March 2002, Transplantation,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
January 2010, Transplantation proceedings,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
August 2004, Journal of the American Society of Nephrology : JASN,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
December 2003, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
April 2010, Indian journal of nephrology,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
October 2009, Indian journal of nephrology,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
April 1998, Kidney international,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
October 2001, Nephron,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
July 2006, Nihon rinsho. Japanese journal of clinical medicine,
P M Biselli, and M Abbud-Filho, and M A S Ferreira-Baptista, and M P S de Alvarenga, and E M Goloni-Bertollo, and E C Pavarino-Bertelli
March 1997, Zhonghua yi xue za zhi,
Copied contents to your clipboard!